Investment Managers Series Trus (IREX)

Key Updates

IREX has declined a further 6.78% to $13.89 since the August 5 report ($14.90), unwinding additional gains from the sharp recovery rally that began at the July 31 intraday low of $11.60. The pullback confirms that the bounce — which peaked near $15.68 on August 4 — has failed to establish durable support, with price now retracing toward the lower end of the recent recovery range. Three additional news items have emerged since the last report, all focused on structural risks, record fund closures, and regulatory scrutiny within the leveraged ETF space, collectively reinforcing the bear case for IREX.

Current Trend

The YTD trend remains deeply negative at -54.25%, placing IREX among the worst-performing products in the leveraged ETF universe this year. Key observations on price action:

• The 1-day (+1.76%) and 5-day (+3.66%) bounces offer marginal near-term relief but are insufficient to alter the dominant downtrend.
• The 1-month return of -18.29% and 6-month return of -54.65% confirm sustained, structural selling pressure rather than isolated volatility.
• Price has now declined 11.4% from the August 4 peak of $15.68, suggesting the recovery rally has exhausted its momentum and the fund is at risk of retesting the July 31 intraday low of $11.60.
• Since the prior report, IREX has shed -6.78%, consistent with the pattern of lower highs and continued deterioration in investor confidence.

Investment Thesis

IREX, as a leveraged ETF product under the Investment Managers Series Trust, is structurally exposed to the compounding risks inherent in daily-reset leveraged instruments. The investment thesis — whether bullish or bearish — must account for: (1) volatility decay eroding NAV over time regardless of directional accuracy; (2) the broader leveraged ETF market experiencing record closure rates in 2026; (3) growing regulatory pressure internationally that could set precedents for domestic restrictions; and (4) the fund's catastrophic YTD drawdown of -54.25%, which structurally disadvantages any long-term recovery thesis absent a dramatic reversal in the underlying exposure.

Thesis Status

The bearish thesis has strengthened materially with this update. The failure of the recovery rally to hold above $15.00 and the resumption of the downtrend, combined with three new data points confirming systemic risk in the leveraged ETF sector, suggest that IREX's structural headwinds are intensifying rather than abating. The record pace of leveraged ETF closures (73 funds shut down through July 23, 2026 — more than triple all of 2025) raises a non-trivial risk of fund discontinuation. Any bullish thesis predicated on a sustained mean-reversion recovery must contend with persistent volatility decay, fee drag (management fees plus 5-6% swap costs), and a market environment increasingly hostile to leveraged products.

Key Drivers

The following developments are materially relevant to IREX's near-term outlook:

• Record leveraged ETF closures: 73 leveraged/inverse ETFs were shut down through July 23, 2026 — 43% of all U.S.-listed ETF closures this year and more than triple the 22 closures in all of 2025. This directly elevates closure risk for subscale funds like IREX. (Morningstar, July 28)
• Catastrophic single-day losses precedent: The GraniteShares 2x Long LCID Daily ETF lost 51% of its value in a single day in July 2026, illustrating the tail risk inherent in leveraged structures and the speed at which NAV destruction can occur. (Morningstar, July 28)
• Volatility decay confirmed by market data: Both bullish and bearish leveraged ETFs on MicroStrategy lost approximately 95% of their value while the underlying stock declined only 38%, illustrating how daily-reset mechanics destroy value for longer-term holders irrespective of directional accuracy. (Business Insider, July 20)
• Institutional skepticism rising: Research Affiliates founder Rob Arnott is actively positioning against both bullish and bearish leveraged ETF trends, signaling that sophisticated institutional capital views current retail enthusiasm as a risk factor rather than a demand catalyst. (Bloomberg, August 4)
• Regulatory risk expanding: South Korea has already moved to restrict new leveraged ETF approvals and increase investor requirements following leveraged ETFs accounting for up to 35% of daily stock turnover and contributing to historic market volatility. Regulatory contagion to U.S. markets represents a growing tail risk. (Business Insider, July 20)

Technical Analysis

IREX is trading at $13.89, positioned within a narrow band between the July 31 intraday low of $11.60 (key support) and the August 4 peak of $15.68 (near-term resistance). Key technical observations:

• Resistance: $15.68 (August 4 peak) — the failed recovery high. A secondary resistance level exists near $14.90 (August 5 close), now acting as overhead supply.
• Support: $11.60 (July 31 intraday low) — the critical structural floor. A breach of this level would represent new multi-period lows and likely accelerate outflows.
• Pattern: The price action since July 31 describes a sharp but fading recovery rally (lower highs forming), consistent with a bear market bounce rather than a trend reversal. The -6.78% decline since the last report and -11.4% decline from the August 4 peak suggest momentum has shifted back to the downside.
• YTD context: At -54.25% YTD, the fund has destroyed more than half its value, consistent with severe volatility decay compounding against the underlying exposure over a sustained period.

Bull Case

• 1. Broad leveraged ETF AUM growth provides sector tailwind: Despite closures, the leveraged ETF category has grown to nearly $200 billion in AUM with approximately 700 listed products, and the largest fund (ProShares UltraPro QQQ) manages ~$33 billion, demonstrating that scale and investor demand can sustain well-positioned products. (Morningstar, July 28)
• 2. Record product launches indicate persistent retail demand: Leveraged and inverse ETFs represented 31% of all U.S.-listed ETF launches in H1 2026, up from 22% in all of 2025, with 117 products debuting in June alone — indicating that investor appetite for leveraged exposure remains robust and could support inflows into surviving funds. (Morningstar, July 9)
• 3. Short-term price momentum has turned modestly positive: The 1-day (+1.76%) and 5-day (+3.66%) returns indicate nascent near-term buying interest, and the fund has not breached the July 31 intraday low of $11.60, preserving a technical floor. (Price data)
• 4. High trading volume environment benefits leveraged products: Leveraged ETFs generate 15-20% of daily ETF trading volume despite representing only 2% of industry assets, suggesting structural liquidity advantages that can attract active traders and short-term capital. (Morningstar, July 9)
• 5. Retail investor behavioral shift toward leveraged products: A growing cohort of retail investors in the U.S. and South Korea are using leveraged ETFs for longer-term positioning, potentially broadening the investor base and supporting sustained demand even as institutional players remain cautious. (Bloomberg, August 4)

Bear Case

• 1. Record fund closure rate poses direct discontinuation risk: 73 leveraged/inverse ETFs were closed through July 23, 2026 — more than triple all of 2025's closures and 43% of all U.S. ETF closures this year. Subscale funds that fail to attract sufficient assets face forced liquidation, representing a binary risk for IREX holders. (Morningstar, July 28)
• 2. Structural volatility decay guarantees NAV erosion over time: Market data confirms that both bullish and bearish leveraged ETFs on MicroStrategy lost ~95% of their value while the underlying stock declined only 38%. IREX's -54.25% YTD loss is consistent with this structural decay mechanism, which compounds irreversibly against long-term holders. (Business Insider, July 20)
• 3. Extreme fee drag compounds losses: Leveraged ETFs carry management fees of approximately 1% plus 5-6% swap costs annually, creating a structural performance headwind that erodes NAV even in favorable market conditions and accelerates losses in adverse ones. (Business Insider, July 20)
• 4. International regulatory precedent threatens domestic market access: South Korea has restricted new leveraged ETF approvals and increased investor qualification requirements after these products contributed to historic market volatility. Regulatory contagion to U.S. markets could materially restrict the investor base and reduce AUM for products like IREX. (Business Insider, July 20)
• 5. Institutional capital actively positioned against leveraged ETF sector: Research Affiliates founder Rob Arnott is positioning against both bullish and bearish leveraged ETF trends, reflecting a growing institutional consensus that current retail enthusiasm in leveraged products represents a risk-on excess rather than a sustainable investment trend. (Bloomberg, August 4)